Clinical Trials Directory

Trials / Conditions / Advanced Solid Cancer

Advanced Solid Cancer

15 registered clinical trials studyying Advanced Solid Cancer — 8 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors
NCT07265921
Jiangsu Simcere Pharmaceutical Co., Ltd.Phase 1
RecruitingA Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Soli
NCT07123415
Aptabio Therapeutics, Inc.Phase 1
Not Yet RecruitingPersonalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors
NCT07196579
TCRx Therapeutics Co.LtdPhase 1
Not Yet RecruitingStudy of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors
NCT07088588
Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdPhase 1
RecruitingA Study of MHB046C Injection in Patients With Advanced Solid Tumors
NCT06985355
Minghui Pharmaceutical (Hangzhou) LtdPhase 1 / Phase 2
RecruitingA Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
NCT07023731
Arvinas Inc.Phase 1 / Phase 2
RecruitingStudy of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
NCT06666270
Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdPhase 1
Active Not RecruitingORB-011 In Patients With Advanced Solid Tumors
NCT05947474
Orionis Biosciences IncPhase 1
UnknownA Phase I Study Of JS015 in Patients With Advanced Solid Tumors
NCT05770310
Shanghai Junshi Bioscience Co., Ltd.Phase 1
Active Not RecruitingA Study of SHR-A1904 in Patients With Advanced Solid Cancer
NCT04877717
Shanghai Hengrui Pharmaceutical Co., Ltd.Phase 1
Active Not RecruitingA Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor
NCT03791112
Betta Pharmaceuticals Co., Ltd.Phase 1
RecruitingAPG-2449 in Patients With Advanced Solid Tumors
NCT03917043
Ascentage Pharma Group Inc.Phase 1
TerminatedClinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer
NCT03884517
Bio-Thera SolutionsPhase 1
UnknownSafety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer
NCT03618043
Nanjing Sanhome Pharmaceutical, Co., Ltd.Phase 1
TerminatedA Phase I Study of Henatinib in Patients With Advanced Solid Malignancies
NCT01416623
Jiangsu HengRui Medicine Co., Ltd.Phase 1